Gain of function mutations in p53

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Tumor suppressor genes, like p53, play critical roles in preventing cancer.
• Mutations in p53 are common in human cancers and are traditionally associated with a loss of its tumor-suppressive functions.
• The functional consequences of p53 mutations beyond loss of function are not fully understood.

Purpose of the Study:

• To investigate whether mutant p53 proteins can confer new or additional functions to cells lacking endogenous p53.
• To determine if mutant p53 expression impacts cellular phenotypes such as tumorigenicity and gene regulation.

Main Methods:

• Expression of murine or human mutant p53 proteins in p53-null cell lines (e.g., mouse (10)3 cells, human SAOS-2 cells).
• Assessment of tumorigenic potential in nude mice.
• Evaluation of plating efficiency in agar cell culture.
• Analysis of the effect of mutant p53 on the expression of a reporter gene regulated by the multi-drug resistance enhancer-promoter element.

Main Results:

• Expression of mutant p53 in p53-null cells resulted in enhanced tumorigenic potential in vivo.
• Mutant p53 expression led to increased plating efficiency in soft agar, indicating altered cell growth characteristics.
• Unlike wild-type p53, mutant p53 enhanced the expression of a test gene driven by the multi-drug resistance enhancer-promoter.

Conclusions:

• Mutant p53 proteins can exhibit a gain of function, conferring novel oncogenic phenotypes.
• These findings demonstrate that p53 mutations can lead to both loss of tumor suppression and acquisition of new oncogenic functions.
• The gain of function by mutant p53 may contribute to tumor development and progression.